Analysis and Commentary STEVEN GROSSMAN 4/6/18 Analysis and Commentary STEVEN GROSSMAN 4/6/18 A Hill Day Q&A ... Please Join Us Read More Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Support FDA By Participating In the Alliance’s Hill Day on April 25 Read More Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More STEVEN GROSSMAN 3/22/18 STEVEN GROSSMAN 3/22/18 Alliance Thanks Appropriators for Continued Support of FDA Read More Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More Analysis and Commentary STEVEN GROSSMAN 3/11/18 Analysis and Commentary STEVEN GROSSMAN 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More Advocacy at a Glance STEVEN GROSSMAN 3/11/18 Advocacy at a Glance STEVEN GROSSMAN 3/11/18 FDA’s Breakthrough Device Program Featured and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Making the Case: The Alliance's "Ask" for FY 19 Read More Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Alliance Announces Its FY 19 Request; Tells Congress that FDA Needs More Support and more Read More Analysis and Commentary STEVEN GROSSMAN 2/23/18 Analysis and Commentary STEVEN GROSSMAN 2/23/18 First Impressions and Key Priorities on the Hill Read More Advocacy at a Glance STEVEN GROSSMAN 2/23/18 Advocacy at a Glance STEVEN GROSSMAN 2/23/18 Congress Was in Recess and the Alliance Was Busy and more Read More Analysis and Commentary STEVEN GROSSMAN 2/16/18 Analysis and Commentary STEVEN GROSSMAN 2/16/18 And Now for Something a Little Different! Read More Advocacy at a Glance STEVEN GROSSMAN 2/16/18 Advocacy at a Glance STEVEN GROSSMAN 2/16/18 Major Boost for Medical Products, No Increase for Food Safety and more Read More STEVEN GROSSMAN 2/12/18 STEVEN GROSSMAN 2/12/18 Alliance "Applauds" President's FY 19 Budget Request Read More Analysis and Commentary STEVEN GROSSMAN 2/9/18 Analysis and Commentary STEVEN GROSSMAN 2/9/18 The President's Budget Request: Separating the Wheat from the Chaff Read More Advocacy at a Glance STEVEN GROSSMAN 2/9/18 Advocacy at a Glance STEVEN GROSSMAN 2/9/18 The Alliance is Grateful to Dr. Gottlieb for Addressing Our Members on February 6 and more Read More Analysis and Commentary STEVEN GROSSMAN 2/2/18 Analysis and Commentary STEVEN GROSSMAN 2/2/18 The Morning After Effect (on the President's Budget Request) Read More Advocacy at a Glance STEVEN GROSSMAN 2/2/18 Advocacy at a Glance STEVEN GROSSMAN 2/2/18 Opportunities to Become More Involved with the Alliance and more Read More Newer Posts Older Posts
Analysis and Commentary STEVEN GROSSMAN 4/6/18 Analysis and Commentary STEVEN GROSSMAN 4/6/18 A Hill Day Q&A ... Please Join Us Read More
Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Advocacy at a Glance STEVEN GROSSMAN 4/6/18 Support FDA By Participating In the Alliance’s Hill Day on April 25 Read More
Analysis and Commentary STEVEN GROSSMAN 3/23/18 Analysis and Commentary STEVEN GROSSMAN 3/23/18 FDA Appropriations for FY 18 and FY 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Advocacy at a Glance STEVEN GROSSMAN 3/23/18 Congress Unveils Final FY 18 Consolidated Appropriations Bill; FDA Funding Increased and more Read More
STEVEN GROSSMAN 3/22/18 STEVEN GROSSMAN 3/22/18 Alliance Thanks Appropriators for Continued Support of FDA Read More
Analysis and Commentary STEVEN GROSSMAN 3/16/18 Analysis and Commentary STEVEN GROSSMAN 3/16/18 Key CDER Priorities Need Funding Too Read More
Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Advocacy at a Glance STEVEN GROSSMAN 3/16/18 Unclear Whether Congress Can Avoid Brinksmanship and more Read More
Analysis and Commentary STEVEN GROSSMAN 3/11/18 Analysis and Commentary STEVEN GROSSMAN 3/11/18 Game-Changing Medical Device Priorities Need Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 3/11/18 Advocacy at a Glance STEVEN GROSSMAN 3/11/18 FDA’s Breakthrough Device Program Featured and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Making the Case: The Alliance's "Ask" for FY 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Advocacy at a Glance STEVEN GROSSMAN 3/3/18 Alliance Announces Its FY 19 Request; Tells Congress that FDA Needs More Support and more Read More
Analysis and Commentary STEVEN GROSSMAN 2/23/18 Analysis and Commentary STEVEN GROSSMAN 2/23/18 First Impressions and Key Priorities on the Hill Read More
Advocacy at a Glance STEVEN GROSSMAN 2/23/18 Advocacy at a Glance STEVEN GROSSMAN 2/23/18 Congress Was in Recess and the Alliance Was Busy and more Read More
Analysis and Commentary STEVEN GROSSMAN 2/16/18 Analysis and Commentary STEVEN GROSSMAN 2/16/18 And Now for Something a Little Different! Read More
Advocacy at a Glance STEVEN GROSSMAN 2/16/18 Advocacy at a Glance STEVEN GROSSMAN 2/16/18 Major Boost for Medical Products, No Increase for Food Safety and more Read More
STEVEN GROSSMAN 2/12/18 STEVEN GROSSMAN 2/12/18 Alliance "Applauds" President's FY 19 Budget Request Read More
Analysis and Commentary STEVEN GROSSMAN 2/9/18 Analysis and Commentary STEVEN GROSSMAN 2/9/18 The President's Budget Request: Separating the Wheat from the Chaff Read More
Advocacy at a Glance STEVEN GROSSMAN 2/9/18 Advocacy at a Glance STEVEN GROSSMAN 2/9/18 The Alliance is Grateful to Dr. Gottlieb for Addressing Our Members on February 6 and more Read More
Analysis and Commentary STEVEN GROSSMAN 2/2/18 Analysis and Commentary STEVEN GROSSMAN 2/2/18 The Morning After Effect (on the President's Budget Request) Read More
Advocacy at a Glance STEVEN GROSSMAN 2/2/18 Advocacy at a Glance STEVEN GROSSMAN 2/2/18 Opportunities to Become More Involved with the Alliance and more Read More
